全文获取类型
收费全文 | 1168篇 |
免费 | 75篇 |
国内免费 | 69篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 42篇 |
基础医学 | 737篇 |
口腔科学 | 1篇 |
临床医学 | 24篇 |
内科学 | 99篇 |
皮肤病学 | 15篇 |
神经病学 | 5篇 |
特种医学 | 10篇 |
外科学 | 6篇 |
综合类 | 114篇 |
预防医学 | 63篇 |
眼科学 | 5篇 |
药学 | 65篇 |
中国医学 | 102篇 |
肿瘤学 | 3篇 |
出版年
2023年 | 7篇 |
2022年 | 5篇 |
2021年 | 38篇 |
2020年 | 33篇 |
2019年 | 30篇 |
2018年 | 31篇 |
2017年 | 16篇 |
2016年 | 33篇 |
2015年 | 30篇 |
2014年 | 52篇 |
2013年 | 72篇 |
2012年 | 64篇 |
2011年 | 61篇 |
2010年 | 53篇 |
2009年 | 54篇 |
2008年 | 48篇 |
2007年 | 47篇 |
2006年 | 36篇 |
2005年 | 42篇 |
2004年 | 44篇 |
2003年 | 26篇 |
2002年 | 43篇 |
2001年 | 36篇 |
2000年 | 37篇 |
1999年 | 37篇 |
1998年 | 41篇 |
1997年 | 31篇 |
1996年 | 24篇 |
1995年 | 21篇 |
1994年 | 26篇 |
1993年 | 18篇 |
1992年 | 21篇 |
1991年 | 19篇 |
1990年 | 12篇 |
1989年 | 11篇 |
1988年 | 20篇 |
1987年 | 11篇 |
1986年 | 7篇 |
1985年 | 3篇 |
1984年 | 10篇 |
1983年 | 14篇 |
1982年 | 17篇 |
1981年 | 8篇 |
1980年 | 13篇 |
1979年 | 4篇 |
1978年 | 5篇 |
1977年 | 1篇 |
排序方式: 共有1312条查询结果,搜索用时 17 毫秒
1.
2.
目的 探索油菜花粉对小鼠雄激素源性脱发的改善作用并研究其作用机制。方法 设立空白组、模型组、阳性药组及给药组,通过脱毛后涂抹0.2%睾酮诱导建立小鼠雄激素源性脱发模型,采用市售5%米诺地尔为阳性药物,0.4 g·mL-1油菜花粉油溶液为给药组,分别观察小鼠毛发生长速度。通过扫描电子显微镜(scanning electron microscope,SEM)、病理组织HE染色观察小鼠毛发质量及毛囊情况。使用免疫荧光染色、免疫印迹试验检测皮肤中VEGF、bFGF水平,ELISA检测血清性激素及活性氧水平。结果 与模型组相比,油菜花粉能显著促进小鼠毛发生长,且能够改善小鼠毛发毛鳞片的状态。机制探究试验表明油菜花粉不能通过调节小鼠激素水平或抗氧化应激起到促进毛发再生作用,但油菜花粉可以提高造模部位皮肤血管生成相关因子bFGF和VEGF的表达。结论 油菜花粉可以促进雄激素源性脱发小鼠毛发再生,其作用机制可能是通过提高bFGF和VEGF水平,促进毛囊周围血管再生从而达到促进毛发再生作用。 相似文献
3.
Xuan Chen Ren-zhao Wu Ze-ming Ren Ye-ling Tong Sisi Chen Feng Yang Guan-hai Dai 《Andrologia》2020,52(1):e13386
The miRNAs are dysregulated in BPH. Rape bee pollen (RBP) is used to improve benign prostatic hyperplasia (BPH). Whether RBP treats BPH by regulating the dysregulated miRNAs remains unclear. Here, we identified miRNAs regulated along with the improvement of BPH by RBP in posterior lobes of prostate in rats. Firstly, to screened miRNAs might relate to improvement of BPH by RBP, we compared differentially expressed miRNAs between BPH model group and RBP group by high-throughput sequencing. As a result, 10 known miRNAs and 17 novel miRNA were up-regulated in RBP group, and 6 known and 13 novel miRNAs were down-regulated. Secondly, among the known miRNAs, we identified those that might relate to BPH by RT-qPCR, while only rno-miR-184 was screened, so we compared it among normal control group, BPH model group and RBP group. The results showed that rno-miR-184 was significantly lower expressed in BPH group, but up-regulated along with the improvement of BPH by RBP. Moreover, expression level of rno-miR-184 was no difference between RBP group and normal control level. Therefore, we considered that RBP might improve BPH through regulating expression of miRNAs like rno-miR-184 in prostate in rats. 相似文献
4.
Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies,but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma 下载免费PDF全文
5.
Diagnostic relevance of IgE sensitization profiles to eight recombinant Phleum pratense molecules 下载免费PDF全文
F. Cipriani C. Mastrorilli S. Tripodi G. Ricci S. Perna V. Panetta R. Asero A. Dondi A. Bianchi N. Maiello M. Miraglia del Giudice T. Frediani F. Macrì S. Lucarelli I. Dello Iacono M. F. Patria E. Varin D. Peroni L. Chini V. Moschese R. Bernardini G. Pingitore U. Pelosi M. Tosca F. Paravati I. Sfika A. Di Rienzo Businco C. Povesi Dascola P. Comberiati S. Frediani C. Lambiase M. C. Verga D. Faggian M. Plebani M. Calvani C. Caffarelli P. M. Matricardi the Italian Pediatric Allergy Network 《Allergy》2018,73(3):673-682
6.
A randomized,double‐blind,placebo‐controlled,dose‐finding trial with Lolium perenne peptide immunotherapy 下载免费PDF全文
R. Mösges E. M. Kasche E. Raskopf J. Singh L. Sohlich A. Astvatsatourov K. Shah‐Hosseini S. Pirotton L. Haazen S. R. Durham T. Legon G. Zadoyan M. H. Shamji 《Allergy》2018,73(4):896-904
Background
A novel subcutaneous allergen immunotherapy formulation (gpASIT+?) containing Lolium perenne peptides (LPP) and having a short up‐dosing phase has been developed to treat grass pollen–induced seasonal allergic rhinoconjunctivitis. We investigated peptide immunotherapy containing the hydrolysate from perennial ryegrass allergens for the optimum dose in terms of clinical efficacy, immunogenicity and safety.Methods
This prospective, double‐blind, placebo‐controlled, phase IIb, parallel, four‐arm, dose‐finding study randomized 198 grass pollen–allergic adults to receive placebo or cumulative doses of 70, 170 or 370 μg LPP. All patients received weekly subcutaneous injections, with the active treatment groups reaching assigned doses within 2, 3 and 4 weeks, respectively. Efficacy was assessed by comparing conjunctival provocation test (CPT) reactions at baseline, after 4 weeks and after completion. Grass pollen–specific immunoglobulins were analysed before and after treatment.Results
Conjunctival provocation test (CPT) response thresholds improved from baseline to V7 by at least one concentration step in 51.2% (170 μg; P = .023), 46.3% (370 μg), and 38.6% (70 μg) of patients receiving LPP vs 25.6% of patients receiving placebo (modified per‐protocol set). Also, 39% of patients in the 170‐μg group became nonreactive to CPT vs 18% in the placebo group. Facilitated allergen‐binding assays revealed a highly significant (P < .001) dose‐dependent reduction in IgE allergen binding across all treatment groups (70 μg: 17.1%; 170 μg: 18.8%; 370 μg: 26.4%). Specific IgG4 levels increased to 1.6‐fold (70 μg), 3.1‐fold (170 μg) and 3.9‐fold (370 μg) (mPP).Conclusion
Three‐week immunotherapy with 170 μg LPP reduced CPT reactivity significantly and increased protective specific antibodies.7.
8.
9.
Outdoor pollen is a trigger of child and adolescent asthma emergency department presentations: A systematic review and meta‐analysis 下载免费PDF全文
B. Erbas M. Jazayeri K. A. Lambert C. H. Katelaris L. A. Prendergast R. Tham M. J. Parrodi J. Davies E. Newbigin M. J. Abramson S. C. Dharmage 《Allergy》2018,73(8):1632-1641
Background
In the context of increased asthma exacerbations associated with climatic changes such as thunderstorm asthma, interest in establishing the link between pollen exposure and asthma hospital admissions has intensified. Here, we systematically reviewed and performed a meta‐analysis of studies on pollen and emergency department (ED) attendance.Methods
A search for studies with appropriate search strategy in MEDLINE, EMBASE, Web of Science and CINAHL was conducted. Each study was assessed for quality and risk of bias. The available evidence was summarized both qualitatively and meta‐analysed using random‐effects models when moderate heterogeneity was observed.Results
Fourteen studies were included. The pollen taxa investigated differed between studies, allowing meta‐analysis only of the effect of grass pollen. A statistically significant increase in the percentage change in the mean number of asthma ED presentations (MPC) (pooled results from 3 studies) was observed for an increase in 10 grass pollen grains per cubic metre of exposure 1.88% (95% CI = 0.94%, 2.82%). Time series studies showed positive correlations between pollen concentrations and ED presentations. Age‐stratified studies found strongest associations in children aged 5‐17 years old.Conclusion
Exposure to ambient grass pollen is an important trigger for childhood asthma exacerbations requiring ED attendance. As pollen exposure is increasingly a problem especially in relation to thunderstorm asthma, studies with uniform measures of pollen and similar analytical methods are necessary to fully understand its impact on human health. 相似文献10.
Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B‐cell response in seasonal allergic rhinitis patients 下载免费PDF全文
R. Mösges A. F. Koch E. Raskopf J. Singh K. Shah‐Hosseini A. Astvatsatourov B. Hauswald Y. Yarin F. Corazza L. Haazen S. Pirotton S. Allekotte G. Zadoyan T. Legon S. R. Durham M. H. Shamji 《Allergy》2018,73(6):1254-1262